Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN

Abroad (travel likely)Recruiting

Conditions

Hepatocellular Carcinoma (HCC) · Intrahepatic Cholangiocarcinoma (Icc) · Neuroendocrine Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations